Nucleus goes public and lists on AIM

Initial value of £140m

clock • 1 min read

Nucleus has listed on the Alternative Investment Market (AIM) at an expected market capitalisation of £140m.

Dealing on the platform company's shares begun at 8am on Thursday at a placing price of 183p. The gross proceeds of the listing receivable by the selling shareholders could be more than £32m.  The firm, which has more than £14bn assets under administration, said 22.9% of the issued ordinary share capital was sold pursuant to the placing. "This is an important milestone as we continue our work to support and promote the strategic alignment of advisers and their customers," said chief executive David Ferguson. "It's great to see so many institutional investors believing in the growth...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Stories of the week: Defence spending, the FCA, and Brickwood

Stories of the week: Defence spending, the FCA, and Brickwood

The German election, Unilever, and UK GDP: The biggest stories from the world of investment and asset management this week

clock 28 February 2025 • 1 min read
Partner Insight: Uncovering the rich tapestry of emerging markets

Partner Insight: Uncovering the rich tapestry of emerging markets

Global emerging markets comprise a large and varied selection of economies and companies. And yet they are often treated as a homogeneous asset class. We seek to debunk some of the misconceptions about emerging markets and unveil the diverse range of potential opportunities they offer, says M&G Investments.

M&G Investments
clock 28 February 2025 • 3 min read
M&G's Matcham: Concentration risk, consolidation and 'reframing' the active debate

M&G's Matcham: Concentration risk, consolidation and 'reframing' the active debate

Building on history of innovation

Katrina Lloyd
clock 26 February 2025 • 6 min read
Trustpilot